You are here: Industry Insights > mRNA vaccine

News List

Daiichi Sankyo to develop Covid-19 vaccine candidate in Japan pharmaceutical-technology
June 16, 2020
Japanese pharmaceutical company Daiichi Sankyo is set to develop a mRNA vaccine candidate to protect against Covid-19 infection in the country.
Moderna gets FDA fast track status for mRNA vaccine against novel coronavirus pharmaceutical-business-review.
May 14, 2020
Moderna has secured fast track designation from the US Food and Drug Administration (FDA) for its mRNA-1273, the mRNA vaccine candidate against the novel coronavirus (SARS-CoV-2).
NYU Langone to Enroll Patients in US Clinical Trial for COVID-19 mRNA Vaccine americanpharmaceuticalreview
May 07, 2020
The first U.S. patients have been dosed in a clinical trial testing whether four experimental mRNA vaccine candidates can prevent infection with the virus that causes COVID-19 disease.
Sanofi, Translate Bio to develop novel mRNA vaccine for COVID-19 disease pharmaceutical-business-review
March 31, 2020
Sanofi’s vaccines global business unit Sanofi Pasteur has collaborated with Translate Bio for the development of a novel messenger RNA (mRNA) vaccine for COVID-19, the disease resulted due to the novel coronavirus SARS-CoV-2.
Sanofi and Translate Bio to develop mRNA vaccine for Covid-19 pharmaceutical-technology
March 30, 2020
Sanofi vaccines division Sanofi Pasteur has partnered with Translate Bio for the development of a messenger RNA (mRNA) vaccine against Covid-19.

Previous page 1 2 3 4 5 Next page